Blood-Based Biomarkers and Long-term Risk of Frailty-Experience From the Swedish AMORIS Cohort.
Alexandra M V WennbergMozhu DingMarcus EbelingNiklas HammarKarin ModigPublished in: The journals of gerontology. Series A, Biological sciences and medical sciences (2021)
Distinct sets of commonly available biomarkers were associated with development of frailty and monitoring these biomarkers in patients may allow for earlier detection and possible prevention of frailty, with the potential for improved quality of life.